TumCG Cancer Research Results

TumCG, Tumor cell growth: Click to Expand ⟱
Source:
Type:
Normal cells grow and divide in a regulated manner through the cell cycle, which consists of phases (G1, S, G2, and M).
Cancer cells often bypass these regulatory mechanisms, leading to uncontrolled proliferation. This can result from mutations in genes that control the cell cycle, such as oncogenes (which promote cell division) and tumor suppressor genes (which inhibit cell division).


Scientific Papers found: Click to Expand⟱
5046- erastin,  SAS,    The structure of erastin-bound xCT–4F2hc complex reveals molecular mechanisms underlying erastin-induced ferroptosis
- Study, Var, NA
xCT/SLC7A11↓, ROS↑, TumCG↓, GSH↓, Ferroptosis↑,
6585- EU,    Anti-Tumor Activity of Eurycoma longifolia Root Extracts against K-562 Cell Line: In Vitro and In Vivo Study
- vitro+vivo, AML, K562
Dose↝, TumCG↓, Apoptosis↑, TumCCA↑, DNAdam↑, Akt↓, Bcl-2↓, PCNA↓,
6384- Eug,    Eugenol modulates the NOD1-NF-κB signaling pathway via targeting NF-κB protein in triple-negative breast cancer cells
- in-vitro, BC, MDA-MB-231 - in-vitro, BC, MDA-MB-453
TumCG↓, TumMeta↓, NF-kB↓,
6355- Eug,    Pharmacological and Toxicological Properties of Eugenol
- Review, Var, NA
*Inflam↓, *antiOx↑, *NF-kB↓, *AntiArt↑, *lipid-P↓, *GSH↑, ROS↑, GSH↓, ChemoSen↑, Apoptosis↑, MMP↓, TumCG↓, TumCCA↑,
6377- Eug,    Pharmacological Properties and Health Benefits of Eugenol: A Comprehensive Review
- Review, Var, NA - Review, AD, NA
*Inflam↓, *Bacteria↓, ChemoSen↑, *selectivity↑, ROS⇅, TumCG↓, MMP↓, antiOx⇅, *antiOx↑, *BBB↑, *neuroP↑, *BDNF↑, *Aβ↓, *Ca+2↓, *5LO↓, *MAOA↓, other↑,
6388- Eug,    Eugenol’s anti-cancer properties, its modulation of signalling pathways, and cascades across various cancers: A review
- Review, Var, NA
Dose↝, AntiCan↑, *Inflam↓, *cardioP↑, *neuroP↑, angioG↓, TumMeta↓, *BioAv↑, *CompStab↑, *toxicity↝, antiNeop↑, TumCCA↑, Apoptosis↑, *antiOx↑, *lipid-P↓, *ROS↓, *SOD↑, *Catalase↑, *GSTs↑, *GPx↑, *iNOS↓, *COX2/PTGS2↓, *IL6↓, *TNF-α↓, *AntiArt↑, *Bacteria↓, TumAuto↑, PI3K↓, Akt↓, FOXO3↝, BAX↑, mTOR↓, NF-kB↓, P53↑, TumCG↓, CSCs↓, CD44↓, EpCAM↓, NOTCH1↓, OCT4↓, Bcl-2↓, PDK1 / PDPK1↓, HER2/EBBR2↓, BAD↓, cycD1/CCND1↓, ROS↑, Casp3↑, selectivity↑, MMP2↓, MMP9↓, TIMP1↑, VEGF↓, VEGFR1↓, RECK↑, TIMP2↑, DNAdam↑, MMP↓, Thiols↓, PARP↑, *Pain↓, E2Fs↓, survivin↓,
6339- Eug,    Induction of apoptosis by eugenol in human breast cancer cells
- in-vitro, BC, NA
TumCG↓, TumCP↓, TumCD↑, GSH↓, lipid-P↑,
6845- EVO,    Evodiamine, a Novel NOTCH3 Methylation Stimulator, Significantly Suppresses Lung Carcinogenesis in Vitro and in Vivo
- vitro+vivo, NSCLC, A549 - in-vitro, Lung, H1299
AntiCan↑, TumVol↓, NOTCH3↓, tumCV↓, TumCCA↑, TumCMig↓, CSCs↓, TumCP↓, Apoptosis↑, TumCI↓, ROS↑, TumCG↓, selectivity↑, DNMT1↓,
6846- EVO,    Evodiamine Inhibits Colorectal Cancer Growth via RTKs Mediated PI3K/AKT/p53 Signaling Pathway
- in-vitro, CRC, HT29 - in-vitro, CRC, HCT116
TumCP↓, TumCI↓, TumCCA↑, PI3K↓, AKT1↓, P53↑, Bcl-2↓, BAX↑, Apoptosis↑, p‑Casp9↑, E-cadherin↑, N-cadherin↓, MMP9↓, CSCs↓, EGFR↓, PDGFRA↓, Dose↝, TumCG↓,
6843- EVO,    Effects of evodiamine on PI3K/Akt and MAPK/ERK signaling pathways in pancreatic cancer cells
- in-vivo, PC, PANC1 - in-vitro, PC, SW1990
Apoptosis↑, LC3II↓, p62↑, Akt↓, ERK↓, p38↓, TumW↓, TumCG↓, TumCMig↓,
1022- EVO,    Evodiamine suppresses non-small cell lung cancer by elevating CD8+ T cells and downregulating the MUC1-C/PD-L1 axis
- in-vivo, Lung, H1975 - in-vitro, Lung, H1650
TumCG↓, Apoptosis↑, TumCCA↑, PD-L1↓, MUC1-C↓, TumVol↓,
6853- FBZ,    Fenbendazole acts as a moderate microtubule destabilizing agent and causes cancer cell death by modulating multiple cellular pathways
- vitro+vivo, Lung, A549 - in-vitro, Lung, H460
TumCD↑, P53↑, GlucoseCon↓, GLUT4↓, HK2↓, TumCG↓, P-gp/ABCB1∅, TumCCA↑, CycB/CCNB1↓, eff↑, selectivity↑, MMP↓, lactateProd↓, Synergy↑, Dose↝, TumCG↓,
6855- FBZ,    Transcriptome analysis reveals the anticancer effects of fenbendazole on ovarian cancer: an in vitro and in vivo study
- vitro+vivo, Ovarian, A2780S - vitro+vivo, Ovarian, SKOV3
TumCP↓, Apoptosis↑, TumCG↓, cl‑Casp3↑, Bax:Bcl2↑, CDK1↓,
2496- FBZ,    Impairment of the Ubiquitin-Proteasome Pathway by Methyl N-(6-Phenylsulfanyl-1H-benzimidazol-2-yl)carbamate Leads to a Potent Cytotoxic Effect in Tumor Cells
- in-vitro, NSCLC, A549 - in-vitro, NSCLC, H460
TumCG↓, selectivity↑, P53↑, IKKα↑, ER Stress↑, GRP78/BiP↑, CHOP/DDIT3↑, ATF3↑, IRE1↑, NOXA↑, ROS↑, MMP↓, Cyt‑c↑, selectivity↑, eff↝,
6427- FEO,    Foeniculum vulgare seed extract exerts anti-cancer effects on hepatocellular carcinoma
- vitro+vivo, HCC, NA
tumCV↓, Apoptosis↑, TumCMig↓, TumCG↓, survivin↓, mtDam↑, Casp3↑,
6891- Fer,    Iron oxide nanoparticles inhibit tumor growth by ferroptosis in diffuse large B-cell lymphoma
- vitro+vivo, lymphoma, NA
TumCG↓, Ferroptosis↑, i-Iron↑, lipid-P↑, GPx4↓, ROS↑, Fenton↑, TfR1/CD71↝, FPN↝, LIP↑, TumCP↓, Apoptosis↑, TumCG↓,
6890- Fer,    Iron oxide nanoparticles inhibit tumour growth by inducing pro-inflammatory macrophage polarization in tumour tissues
- vitro+vivo, Var, NA
TumMeta↓, TumCD∅, Casp3↑, ROS↑, H2O2↑, TumCG↓, Dose↝, other↑,
6897- FIS,    Fisetin: A Dietary Antioxidant for Health Promotion
- Review, Nor, NA
*chemoPv↑, *neuroP↑, *antiOx↑, *GSH↑, *HO-1↑, *NRF2↑, angioG↓, TumCG↓, uPA↓, MMP1↓, tumCV↓, PTEN↑, PI3K↓, p‑Akt↓, AMPK↑, mTOR↓, EGFR↓, NF-kB↓, COX2/PTGS2↓, PGE2↓, Wnt↓, β-catenin/ZEB1↓, TCF↓, cycD1/CCND1↓, MMP7↓, RadioS↑, PSA↓, Securin↓, TumCCA↑, XIAP↓, *ERK↑, *p‑CREB↑, *memory↑, *GSH↑, *Inflam↓, *5LO↓,
6906- FIS,  Rad,    Combining fisetin and ionizing radiation suppresses the growth of mammalian colorectal cancers in xenograft tumor models
- in-vivo, CRC, CT26 - in-vivo, CRC, HCT116
antiOx↑, Inflam↓, angioG↓, TumCI↓, TumCP↓, TumCG↓, RadioS↑,
6901- FIS,    Fisetin induces G2/M phase arrest and caspase-mediated cleavage of p21Cip1 and p27Kip1 leading to apoptosis and tumor growth inhibition in HNSCC
- in-vivo, HNSCC, CAL33
TumCG↓, TumCD↑, selectivity↑, TumCCA↑, CDC25↓, CDK1↓, CycB/CCNB1↓, P53↑, DNAdam↑, Apoptosis↑, γH2AX↑, cl‑PARP↑, other↝, JNK↑, PI3K↓, Akt↓, ERK↓, EGFR↓, STAT3↓, TumAuto↑, Dose↝, TumVol↓, Ki-67↓, cl‑Casp3↑, P21↓, p27/CDKN1B↓,
6898- FIS,    Fisetin induces autophagic cell death through suppression of mTOR signaling pathway in prostate cancer cells
- in-vitro, Pca, PC3 - in-vitro, Pca, DU145 - in-vitro, Pca, LNCaP
mTOR↓, Akt↓, AMPK↑, TumCG↓, mTORC1↓, mTORC2↓, 4E-BP1↑, LC3II↑, TumAuto↑,
6994- FIS,    Fisetin inhibits the activities of cyclin-dependent kinases leading to cell cycle arrest in HT-29 human colon cancer cells
- in-vitro, Colon, HT29
TumCG↓, TumCCA↑, CDK2↓, CDK4↓, cycE/CCNE↓, cycD1/CCND1↓, P21↑,
2859- FIS,    The Natural Flavonoid Fisetin Inhibits Cellular Proliferation of Hepatic, Colorectal, and Pancreatic Cancer Cells through Modulation of Multiple Signaling Pathways
- in-vitro, Liver, HepG2 - NA, Colon, Caco-2
TumCG↓, other↝, Casp3↑, Casp7↑, PGE2↓, GSTs↓, Wnt↓, EGFR↓, NF-kB↓, COX2/PTGS2↓, P53↑, P21↑, P450↓,
2829- FIS,    Fisetin: An anticancer perspective
- Review, Var, NA
TumCP↓, TumCI↓, TumCCA↑, TumCG↓, Apoptosis↑, cl‑PARP↑, PKCδ↓, ROS↓, ERK↓, NF-kB↓, survivin↓, ROS↑, PI3K↓, Akt↓, mTOR↓, MAPK↓, p38↓, HER2/EBBR2↓, EMT↓, PTEN↑, HO-1↑, NRF2↑, MMP2↓, MMP9↓, MMP↓, Casp8↑, Casp9↑, TRAILR↑, Cyt‑c↑, XIAP↓, P53↑, CDK2↓, CDK4↓, CDC25↓, CDC2↓, VEGF↓, DNAdam↑, TET1↓, CHOP/DDIT3↑, CD44↓, CD133↓, uPA↓, CSCs↓,
2830- FIS,    Biological effects and mechanisms of fisetin in cancer: a promising anti-cancer agent
- Review, Var, NA
TumCG↓, angioG↓, *ROS↓, TumCMig↓, VEGF↓, MAPK↑, NF-kB↓, PI3K↓, Akt↓, mTOR↓, NRF2↑, HO-1↑, ROS↓, Inflam↓, ER Stress↑, ROS↑, TumCP↓, ChemoSen↑, PTEN↑, P53↑, Casp3↑, Casp8↑, Casp9↑, COX2/PTGS2↓, Wnt↓, EGFR↓, Mcl-1↓, survivin↓, IAP1↓, IAP2/BIRC3↓, PGE2↓, β-catenin/ZEB1↓, DR5↑, MMP2↓, MMP9↓, FAK↓, uPA↓, EMT↓, ERK↓, JNK↑, p38↑, PKCδ↓, BioAv↓, BioAv↑, BioAv↑,
2831- FIS,    Fisetin as a chemoprotective and chemotherapeutic agent: mechanistic insights and future directions in cancer therapy
- Review, Var, NA
TumCG↓, ER Stress↑, antiOx↓, ROS↓, ChemoSen↑,
2839- FIS,    Dietary flavonoid fisetin for cancer prevention and treatment
- Review, Var, NA
DNAdam↑, ROS↑, Apoptosis↑, Bcl-2↓, BAX↑, cl‑Casp9↑, cl‑Casp3↑, Cyt‑c↑, lipid-P↓, TumCG↓, TumCA↓, TumCMig↓, TumCI↓, uPA↓, ERK↓, MMP9↓, NF-kB↓, cFos↓, cJun↓, AP-1↓, TumCCA↑, AR↓, mTORC1↓, mTORC2↓, TSC2↑, EGF↓, TGF-β↓, EMT↓, P-gp/ABCB1↓, PI3K↓, Akt↓, mTOR↓, Synergy↑, ROS↓, ER Stress↑, IRE1↑, ATF4↑, GRP78/BiP↑, ChemoSen↑, CDK2↓, CDK4↓, cycE/CCNE↓, cycD1/CCND1↓, P21↑, COX2/PTGS2↓, Wnt↓, EGFR↓, β-catenin/ZEB1↓, TCF-4↓, MMP7↓, RadioS↑, Synergy↑,
6982- Form,    Formononetin: A Review of Its Anticancer Potentials and Mechanisms
- Review, Var, NA
AntiTum↑, Apoptosis↑, BAX↑, Bcl-2↓, Casp3↑, TumCCA↑, cycA1/CCNA1↓, CycB/CCNB1↓, cycD1/CCND1↓, TumCP↓, VEGF↓, FGF↓, MMP2↓, MMP9↓, Synergy↑, ChemoSen↑, chemoPv↑, p‑Akt↓, p‑STAT3↑, TumCMig↓, TumCI↓, TIMP1↑, TIMP2↑, PI3K↓, Akt↓, Dose↝, TumCG↓, TumW↓, TumVol↓, angioG↓, Casp3↑, Casp9↑, cl‑PARP↑, DNArepair↓, MMP↓, BAX↑, Bcl-2↓, DR5↑, ROS↑, eff↓, p‑ERK↓, PTEN↑, Hif1a↓, eff↑, Synergy↑, ChemoSen↑, HDAC↓, *BioAv↑, *Half-Life↝, *BioAv↝, *BioAv↑, *BioAv↑, *eff↑,
6984- Form,    Formononetin suppresses colitis-associated colon cancer by targeting lipid synthesis and mTORC2/Akt signaling
- in-vitro, Colon, HCT116 - Review, IBD, RAW264.7
*Inflam↓, AntiCan↑, *NF-kB↓, *MAPK↓, *colonLen↑, TumCG↓, Apoptosis↑, LC3II↑, Beclin-1/ATG6↑, cl‑Casp3↑, BAX↑, Bcl-2↓, IGF-1↓, ACLY↓, Acetyl-CoA↓, Fas↓, HSL/LIPE↓, ATGL/PNPLA2↓, FFA/NEFA↓, GSK‐3β↑, p‑mTOR↓, Rictor↓, p‑Akt↓, PDE3B↓, p‑PKA↓, p‑HSL/LIPE↑, TumAuto↑,
6987- Form,    Formononetin exhibits anticancer activity in gastric carcinoma cell and regulating miR-542-5p
- vitro+vivo, GC, SGC-7901 - in-vitro, BC, MGC803
antiNeop↑, tumCV↓, TumCMig↓, TumCI↓, Dose↝, miR-542↓, TumCG↓,
6993- Form,  ISL,    Novel herbal flavonoids promote apoptosis but differentially induce cell cycle arrest in human colon cancer cell
- in-vitro, CRC, HCT116
AntiTum↑, TumCG↓, Apoptosis↑, Casp↑, Bcl-2↓, Bcl-xL↓,
6976- Form,    Study on the Mechanism of Formononetin Against Hepatocellular Carcinoma: Regulating Metabolic Pathways of Ferroptosis and Cell Cycle
- vitro+vivo, HCC, HepG2
ROS↑, DNAdam↑, TumCCA↑, CHK1↝, CDC25↝, CDK1↝, CycB/CCNB1↝, GSH↓, lipid-P↑, Ferroptosis↑, xCT/SLC7A11↓, P53↓, GPx4↓, other↝, TumCP↓, γH2AX↑, TumCG↓, Ki-67↓, PCNA↓, MMP↓,
6964- Form,    Formononetin induces cell cycle arrest of human breast cancer cells via IGF1/PI3K/Akt pathways in vitro and in vivo
- vitro+vivo, BC, MCF7
IGF-1↓, IGFR↓, PI3K↓, Akt↓, cycD1/CCND1↓, TumCP↓, TumCCA↑, TumCG↓, Dose↝,
6969- Form,    Formononetin inhibits tumor growth by suppression of EGFR-Akt-Mcl-1 axis in non-small cell lung cancer
- vitro+vivo, NSCLC, HCC827 - in-vitro, NSCLC, A549 - in-vitro, Lung, H1299
EGFR↓, Akt↓, GSK‐3β↑, TumCG↓, ChemoSen↑, Mcl-1↓, RadioS↑, tumCV↓, selectivity↑, Dose↝, Cyt‑c↑, BAX↑, Apoptosis↑, Ki-67↓, toxicity↓, chemoPv↑,
6971- Form,    In vitro and in vivo anti-cancer activity of formononetin on human cervical cancer cell line HeLa
- vitro+vivo, Cerv, HeLa
p‑Akt↓, Apoptosis↑, TumCG↓, Dose↝, PI3K↓, eff↑, ATP↓, OCR↓, TumCCA↑, IGF-1↓, angioG↓, TumCI↓,
6972- Form,  PacT,    Formononetin ameliorates the drug resistance of Taxol resistant triple negative breast cancer by inhibiting autophagy
- in-vivo, BC, MDA-MB-231
AntiCan↑, miR-199↓, ChemoSen↑, TumVol↓, Dose↝, TumCG↓, TumCCA↑, Apoptosis↑, TumAuto↓, eff↓,
8313- FS,    Flaxseed and its lignan and oil components: can they play a role in reducing the risk of and improving the treatment of breast cancer?
- Review, BC, NA
TumCG↓, ChemoSen↑, Risk↓, OS↑, TumCP↓, Apoptosis↑,
8584- FS,    Anti-Oxidant and Anti-Cancer Properties of Flaxseed
- Review, Nor, NA
*Ingr↝, *cardioP↑, *LDL↓, *lipidLev↓, *AntiDiabetic↑, *hepatoP↑, *AntiCan↑, *Analgesic↑, *AntiArt↑, *CRP↓, *TNF-α↓, *Inflam↓, *toxicity↝, *neuroP↑, *Ingr↝, *Ingr↝, *AntiViral↑, Risk↓, *Ingr↝, *hs-CRP↓, *GutMicro↑, *TJ↑, *OCLN↝, *MLC2/MYL9↝, *VCAM-1↓, *Akt2↓, *IKKα↓, *NF-kB↓, Synergy↑, HER2/EBBR2↓, MAPK↓, PI3K↓, Akt↓, EGFR↓, TumCG↓, TumMeta↓, IGF-1↓, COX2/PTGS2↓, PGE2↓, CDK4↓, TNF-α↓, IL1β↓, lipid-P↑, P53↑, MDM2↑, cl‑Casp3↑, cl‑PARP↑, cl‑Casp7↑, BAX↑, Bcl-2↓, Bax:Bcl2↑, Cyt‑c↑, Casp9↑, Ki-67↓, CYP1A1↑, p38↑, ERK↑, Synergy↑, ChemoSen↑, *BioAv↑, eff↝, Ingr↝,
8590- FS,    The Effect of Flaxseed in Breast Cancer: A Literature Review
- Review, BC, NA
*BioAv↑, *antiOx↑, *TC↓, *cardioP↑, *Ingr↑, *Ingr↑, chemoP↑, ChemoSen↑, TumVol↓, TumCG↓, Risk↓, Risk↓, Ki-67↓, OS↑, TumMeta↓,
8596- FSO,    Treatment with flaxseed oil induces apoptosis in cultured malignant cells
- in-vitro, BC, MCF7 - in-vitro, Melanoma, B16-BL6
TumCG↓, selectivity↑, Apoptosis↑, DNAdam↑, Casp↑, mtDam↑, cl‑PARP↑, MMP↓,
7022- Fuc,    Antitumor Effects of Fucoidan on Human Colon Cancer Cells via Activation of Akt Signaling
- in-vitro, Colon, HT29
TumCG↓, TumCCA↑, Cyc↓, Akt↑, eff↓, Apoptosis↑, angioG↓,
7007- Fuc,    The Therapeutic Potential of the Anticancer Activity of Fucoidan: Current Advances and Hurdles
- Review, Var, NA
TumCCA↑, Apoptosis↑, NK cell↑, chemoP↑, TumCG↓, *Inflam↓, *antiOx↑, *AntiThr↑, *AntiViral↑, angioG↓, ChemoSen↑, ROS↑, GSH↓, mtDam↓, MMP↓, DNMT3B↓, TumCG↓, Dose↝, Dose↝, QoL∅, fatigue∅, Dose↝,
948- Fuc,    Low Molecular Weight Fucoidan Inhibits Tumor Angiogenesis through Downregulation of HIF-1/VEGF Signaling under Hypoxia
- vitro+vivo, Bladder, T24/HTB-9 - in-vitro, Nor, HUVECs
p‑PI3k/Akt/mTOR↓, p‑p70S6↓, p‑4E-BP1↓, angioG↓, Hif1a↓, VEGF↑, TumCG↓, TumVol↓, TumW↓, Iron∅, ROS↓,
4024- FulvicA,    ANTI-CARCINOGENIC ACTIVITY OF SHILAJIT REGARDING TO APOPTOSIS ASSAY IN CANCER CELLS: A SYSTEMATIC REVIEW OF IN-VITRO STUDIES
- Review, Var, NA
*Inflam↓, *antiOx↑, TumCG↓, tumCV↓, ROS↑, ChemoSen↑, toxicity↝,
7034- GA,  RES,    The Growth Inhibitory Effect of Resveratrol and Gallic Acid on Prostate Cancer Cell Lines through the Alteration of Oxidative Stress Balance: The Interplay between Nrf2, HO-1, and BACH1 Genes
- in-vitro, Pca, PC3 - in-vitro, Pca, DU145
TumCG↓, ROS↓, SOD↑, GPx↑, Catalase↑, GSR↑, GSH↑, HO-1↑, NRF2↑,
7043- GA,    Gallic acid-induced lung cancer cell death is related to glutathione depletion as well as reactive oxygen species increase
- in-vitro, Lung, Calu-1 - in-vitro, Lung, A549
TumCG↓, MMP↓, ROS↑, GSH↓, eff↑, eff↓, eff↑, mtDam↑, Ca+2↑,
7029- GA,    Gallic acid induces G1 phase arrest and apoptosis of triple-negative breast cancer cell MDA-MB-231 via p38 mitogen-activated protein kinase/p21/p27 axis
- in-vitro, BC, MDA-MB-231 - in-vitro, BC, HS587T - in-vitro, Nor, MCF10
AntiTum↑, tumCV↓, selectivity↑, TumCCA↑, cycD1/CCND1↓, CDK4↓, cycE/CCNE↓, CDK2↓, P21↑, p27/CDKN1B↑, Casp9↑, Casp3↑, ROS↑, mtDam↑, i-Ca+2↑, *ROS↓, *Apoptosis↓, TumCG↓,
987- GA,    Targeting Aerobic Glycolysis: Gallic Acid as Promising Anticancer Drug
- in-vitro, GBM, AMGM - in-vitro, Cerv, HeLa - in-vitro, BC, MCF7
LDH↓, TumCG↓,
947- GA,    Gallic acid, a phenolic compound, exerts anti-angiogenic effects via the PTEN/AKT/HIF-1α/VEGF signaling pathway in ovarian cancer cells
- in-vitro, Ovarian, OVCAR-3 - in-vitro, Melanoma, A2780S - in-vitro, Nor, IOSE364 - Human, NA, NA
TumCG↓, VEGF↓, angioG↓, p‑Akt↓, Hif1a↓, PTEN↑, BioAv↑, *toxicity↓,
5207- Gallo,    Targeting pancreatic cancer with combinatorial treatment of CPI-613 and inhibitors of lactate metabolism
- in-vitro, PC, NA
LDH↓, TumCP↓, TumCG∅,

Showing Research Papers: 401 to 450 of 989
Prev Page 9 of 20 Next

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 989

Pathway results for Effect on Cancer / Diseased Cells:


NA, unassigned(tgid=0) ⓘ

NA↓, 1,   NA↑, 1,   NA↝, 1,  

Redox & Oxidative Stress(tgid=1) ⓘ

antiOx↓, 2,   antiOx↑, 6,   antiOx⇅, 1,   ARE↑, 1,   Catalase↓, 5,   Catalase↑, 4,   ENOX2↓, 2,   Fenton↑, 7,   GPx↓, 3,   GPx↑, 4,   GPx4↓, 19,   GSH↓, 52,   GSH↑, 3,   i-GSH↓, 1,   GSH/GSSG↓, 5,   GSR↓, 1,   GSR↑, 1,   GSSG↓, 1,   GSTs↓, 1,   H2O2↓, 4,   H2O2↑, 10,   i-H2O2↑, 1,   mt-H2O2↑, 1,   HO-1↓, 8,   HO-1↑, 11,   hyperG↓, 1,   Iron↓, 2,   Iron↑, 11,   Iron∅, 1,   i-Iron↑, 3,   c-Iron↑, 1,   Keap1↑, 1,   lipid-P↓, 4,   lipid-P↑, 20,   MDA↓, 2,   MDA↑, 11,   NADH↓, 1,   NADHdeh?, 1,   NADPH/NADP+↓, 2,   NOX2↑, 1,   NQO1?, 1,   NQO1↓, 1,   NQO1↑, 3,   Nrf1↓, 1,   Nrf1↑, 1,   NRF2↓, 15,   NRF2↑, 16,   NRF2↝, 1,   ox-PrxI↑, 1,   RNS↑, 2,   ROMO1↑, 1,   ROS?, 3,   ROS↓, 21,   ROS↑, 274,   ROS⇅, 3,   ROS↝, 2,   ROS∅, 1,   i-ROS↑, 1,   mt-ROS↑, 9,   SOD↓, 5,   SOD↑, 4,   SOD1↓, 2,   SOD1↑, 1,   SOD2↓, 4,   SOD2↑, 6,   TAC↓, 3,   TBARS↓, 1,   Thiols↓, 1,   i-Thiols↓, 1,   TKT↝, 1,   TOS↑, 1,   Trx↓, 2,   Trx↑, 1,   Trx1↓, 2,   ox-Trx1↑, 1,   TrxR↓, 7,   TrxR↑, 1,   TrxR1↓, 3,   xCT/SLC7A11↓, 12,  

Metal & Cofactor Biology(tgid=2) ⓘ

Ferritin↓, 3,   Ferritin↑, 1,   FPN↝, 1,   FTH1↓, 3,   IronCh↑, 1,   LIP↑, 1,   NCOA4↑, 2,   Tf↑, 1,   TfR1/CD71↓, 1,   TfR1/CD71↝, 1,  

Mitochondria & Bioenergetics(tgid=3) ⓘ

CDC2↓, 3,   p‑CDC2↓, 1,   CDC25↓, 10,   CDC25↑, 2,   CDC25↝, 1,   compI↓, 2,   compIII↓, 1,   EGF↓, 2,   ETC↓, 8,   HSP60/HSPD1↓, 4,   HSP60/HSPD1↑, 1,   Insulin↓, 3,   mitResp↓, 7,   mitResp↑, 2,   mtDam?, 1,   mtDam↓, 2,   mtDam↑, 26,   OCR↓, 10,   OCR↑, 5,   OXPHOS↓, 5,   OXPHOS↑, 10,   mt-OXPHOS↓, 1,   PDH↓, 2,   PDH↑, 6,   p‑PDH↓, 1,   PGC-1α↓, 1,   PGC-1α↑, 1,   PHB↑, 1,   PINK1↑, 2,   SIRT3↑, 2,  

Core Metabolism/Glycolysis(tgid=4) ⓘ

12LOX↓, 3,   5LO↓, 3,   ACC↓, 1,   ACC-α↓, 2,   ACC1↓, 1,   Acetyl-CoA↓, 1,   ACLY↓, 5,   ACSL4↑, 3,   Alanine↓, 1,   ALAT↓, 5,   ALAT∅, 1,   AMP↓, 1,   AMPK↓, 2,   AMPK↑, 23,   AMPK↝, 1,   p‑AMPK↑, 4,   ARG↓, 1,   ATGL/PNPLA2↓, 1,   ATP↓, 38,   ATP↑, 3,   i-ATP↑, 1,   Buty↑, 1,   CAIX/CA9↓, 1,   CAIX/CA9↑, 1,   cAMP↓, 1,   cAMP⇅, 1,   i-citrate↑, 1,   CRM↑, 3,   DHODH↓, 1,   ECAR↓, 7,   ECAR∅, 1,   ENO1↓, 3,   FABP4↑, 1,   FABP5/E-FABP↓, 1,   FASN↓, 7,   FDG↓, 1,   FFA/NEFA↓, 1,   G6PD↓, 1,   GALNT10↓, 1,   GAPDH↓, 4,   GLS↓, 1,   glucoNG↓, 1,   glucose↓, 2,   GlucoseCon↓, 26,   GlucoseCon↑, 3,   GlutMet↓, 1,   Glycine↓, 1,   Glycolysis↓, 57,   Glycolysis↑, 2,   GPI↓, 1,   GSK‐3β↓, 4,   GSK‐3β↑, 4,   p‑GSK‐3β↓, 2,   p‑GSK‐3β↑, 1,   HK2↓, 25,   HK2∅, 1,   HMG-CoA↓, 7,   HSL/LIPE↓, 1,   p‑HSL/LIPE↑, 1,   IDH1↑, 1,   KeyT↑, 1,   lactateProd↓, 29,   lactateProd↑, 2,   LDHA↓, 19,   LDHA∅, 1,   LDL↓, 2,   lipidLev↓, 1,   lipoGen↓, 2,   MATs↓, 1,   MCT4↓, 2,   MethCyc↓, 1,   NAD↓, 2,   NADPH↓, 1,   NADPH↑, 1,   NPC1L1↓, 1,   PA↑, 2,   PDK1 / PDPK1↓, 8,   PDKs↓, 4,   PFK↓, 4,   PFK1↓, 5,   PFKP↓, 3,   PKM1↑, 1,   PKM2↓, 21,   p‑PKM2↓, 1,   polyA↓, 1,   PPP↓, 2,   Pyruv↓, 3,   Pyruv↑, 1,   R5P↝, 1,   SCFAs↑, 1,   SIRT1↓, 8,   SIRT1↑, 3,   SREBF2↓, 1,   SREBP1/SREBF1↓, 4,   TCA↓, 2,   TCA↑, 2,   TPI↓, 1,   TS↓, 1,   Warburg↓, 14,   Warburg↑, 1,  

Cell Death(tgid=5) ⓘ

AIF↑, 11,   APAF1↑, 1,   Apoptosis↓, 12,   Apoptosis↑, 381,   Apoptosis∅, 2,   mt-Apoptosis↑, 1,   ASC↑, 1,   ASK1↑, 1,   BAD↓, 3,   BAD↑, 3,   Bak↑, 3,   BAX↓, 2,   BAX↑, 113,   BAX↝, 1,   Bax:Bcl2↑, 32,   Bcl-2?, 1,   Bcl-2↓, 150,   Bcl-2↑, 1,   Bcl-xL↓, 36,   Bcl-xL↑, 3,   BID↓, 1,   BID↑, 5,   cl‑BID↑, 1,   BIM↑, 6,   BNIP3↑, 1,   BNIP3↝, 1,   Casp↑, 38,   Casp↝, 1,   Casp1↓, 2,   Casp1↑, 1,   cl‑Casp1↑, 1,   Casp12↑, 1,   Casp3?, 1,   Casp3↓, 3,   Casp3↑, 134,   cl‑Casp3↓, 1,   cl‑Casp3↑, 52,   proCasp3↓, 1,   CASP4↑, 2,   Casp6↓, 1,   Casp6↑, 1,   Casp7↑, 17,   cl‑Casp7↑, 4,   Casp8↓, 1,   Casp8↑, 32,   cl‑Casp8↑, 11,   Casp9↓, 1,   Casp9↑, 65,   p‑Casp9↑, 1,   cl‑Casp9↓, 1,   cl‑Casp9↑, 12,   cFLIP↓, 2,   Cupro↑, 1,   Cyt‑c↓, 1,   Cyt‑c↑, 77,   Cyt‑c↝, 1,   cl‑Cyt‑c↑, 1,   Diablo↑, 1,   DR5↑, 11,   Endon↑, 1,   FADD↑, 3,   Fap1↓, 1,   Fas↓, 4,   Fas↑, 7,   FasL↓, 2,   FasL↑, 5,   Ferroptosis↓, 1,   Ferroptosis↑, 31,   GSDMC↑, 1,   GSDMD↑, 1,   cl‑GSDMD↑, 1,   cl‑GSDME↑, 3,   GSDME-N↑, 1,   HEY1↓, 2,   IAP1↓, 7,   IAP2/BIRC3↓, 3,   ICD↑, 2,   iNOS↓, 4,   Mcl-1↓, 17,   MDM2↓, 6,   MDM2↑, 1,   MLKL↑, 2,   p‑MLKL↓, 1,   MOMP↑, 2,   Necroptosis↑, 4,   necrosis↑, 6,   NOXA↑, 3,   p38↓, 5,   p38↑, 13,   p‑p38↓, 3,   p‑p38↑, 3,   PUMA↑, 3,   Pyro↑, 11,   RIP3↑, 2,   p‑RIP3↑, 2,   survivin↓, 48,   survivin↑, 1,   TNFR 1↑, 1,   TRAIL↑, 2,   TRAILR↑, 1,   TumCD↓, 2,   TumCD↑, 26,   TumCD∅, 1,   TUNEL↑, 1,   XIAP↓, 17,   YAP/TEAD↓, 10,   YAP/TEAD↑, 2,  

Kinase & Signal Transduction(tgid=6) ⓘ

ABL1↓, 1,   Akt↓, 117,   Akt↑, 6,   p‑Akt↓, 41,   p‑Akt↑, 1,   AKT1↓, 4,   BCAP↓, 1,   BRAF↓, 2,   BRAF↑, 1,   CaMKII ?, 1,   CaMKII ↓, 3,   CIP2A↓, 1,   cMET↓, 5,   CREB↓, 2,   p‑CREB↓, 1,   cSrc↓, 1,   DDIT4?, 1,   DYRK1B↓, 1,   EGFR↓, 29,   EGFR↝, 1,   p‑EGFR↓, 1,   ERK↓, 24,   ERK↑, 6,   ERK↝, 1,   p‑ERK↓, 15,   p‑ERK↑, 3,   e-ERK↑, 1,   FLT3↓, 1,   FOXD3↑, 1,   HER2/EBBR2↓, 10,   p‑HER2/EBBR2↓, 1,   HGF/c-Met↓, 3,   Hippo↑, 1,   IGF-1R↓, 4,   p‑IGF-1R↓, 1,   IGFR↓, 3,   p‑IGFR↓, 1,   IKKα↓, 8,   IKKα↑, 1,   p‑IKKα↓, 2,   IκB↑, 1,   p‑IκB↓, 2,   JAK↓, 4,   JAK1?, 1,   JAK1↓, 3,   p‑JAK1↓, 2,   JAK2↓, 13,   p‑JAK2↓, 4,   JNK↓, 3,   JNK↑, 15,   JNK↝, 1,   p‑JNK↓, 2,   p‑JNK↑, 3,   cl‑JNK↑, 1,   LIFR/CD118↓, 1,   MAPK↓, 18,   MAPK↑, 11,   p‑MAPK↑, 2,   MARK4↓, 1,   MEK↓, 3,   MEK↑, 1,   p‑MEK↓, 1,   mTOR↓, 64,   mTOR↑, 7,   p‑mTOR↓, 8,   p‑mTOR↑, 1,   mTORC2↓, 2,   mTORC2↑, 1,   NIK↓, 1,   OR13G1?, 1,   p‑p70S6↓, 2,   P70S6K↓, 4,   P70S6K↑, 1,   p‑P70S6K↓, 2,   p‑P70S6K↑, 1,   PDE3B↓, 1,   PDGFR-BB↓, 1,   PDGFRA↓, 3,   PDGFRB↓, 1,   PI3K↓, 79,   PI3K↑, 2,   PI3K↝, 1,   p‑PI3K↓, 6,   PI3K/Akt↓, 4,   PI3K/Akt↑, 1,   p‑PI3k/Akt/mTOR↓, 1,   PKA↓, 2,   p‑PKA↓, 1,   PKCδ↓, 5,   p‑PKCδ↓, 2,   PPP2R1A↑, 1,   PTEN↓, 3,   PTEN↑, 15,   PTK2B / PYK2↓, 1,   Raf↓, 3,   RAS↓, 5,   Rictor↓, 1,   RIP1↑, 1,   RSK2/RPS6KA3/p90RSK2↓, 1,   Sp1/3/4↓, 12,   Sp1/3/4↑, 1,   Src↓, 3,   STAT↓, 4,   STAT3↓, 64,   STAT3↑, 1,   STAT3↝, 1,   p‑STAT3↓, 16,   p‑STAT3↑, 2,   STAT4↑, 1,   STAT5↓, 2,   p‑STAT5↓, 1,   SYK↑, 1,   TSC2↑, 1,  

Transcription & Epigenetics(tgid=7) ⓘ

ATF1↓, 1,   ATF2↓, 1,   ATF3↑, 2,   ATF4↑, 10,   BRD4↓, 1,   CBP↓, 1,   ChrMod↑, 2,   cJun↓, 3,   cJun↑, 2,   cMyc↓, 37,   cMyc↑, 1,   DNMT1↓, 6,   DNMT3A↓, 1,   DNMT3B↓, 2,   DNMTs↓, 5,   EZH2↓, 3,   FOXM1↓, 2,   FOXO1↓, 2,   FOXO1↑, 3,   FOXO3↓, 1,   FOXO3↑, 3,   FOXO3↝, 1,   p‑FOXO3↓, 1,   GATA3↓, 1,   H19↑, 1,   H3↓, 2,   H3↑, 1,   ac‑H3↑, 2,   H3K4↓, 1,   H3K9↓, 1,   H4↑, 1,   ac‑H4↑, 1,   HATs↓, 2,   HATs↑, 1,   HDAC↓, 27,   HDAC↑, 1,   HDAC1↓, 2,   HDAC2↓, 4,   HDAC3↓, 2,   HDAC4↓, 1,   HDAC6↓, 1,   HDAC8↓, 2,   HMTs↓, 1,   KLF2↓, 1,   KLF5↓, 1,   miR-106b↓, 1,   miR-122-5p↑, 1,   miR-133a-3p↑, 1,   miR-139-5p↑, 1,   miR-140↑, 1,   miR-141↑, 1,   miR-155↓, 1,   miR-199↓, 1,   miR-200b↑, 1,   miR-200c↑, 1,   miR-203↑, 1,   miR-205↑, 2,   miR-21↓, 3,   miR-22↑, 1,   miR-27a-3p↓, 2,   miR-29b↓, 1,   miR-29b↑, 1,   miR-30a-5p↑, 1,   miR-330-5p↑, 1,   miR-34a↓, 1,   miR-34a↑, 4,   miR-375↑, 1,   miR-486↑, 1,   miR-542↓, 1,   Myc↓, 5,   MYCN↑, 1,   OCT4↓, 15,   OLIG2↓, 1,   other?, 1,   other↓, 4,   other↑, 8,   other↝, 27,   PhotoS↑, 1,   SD↑, 1,   SOX2↓, 9,   SOX9↓, 2,   SUV39H↓, 7,   SUZ12↓, 1,   TCF-4↓, 1,   tumCV?, 1,   tumCV↓, 81,   tumCV∅, 2,  

Protein Folding & ER Stress(tgid=8) ⓘ

ATF6↑, 2,   CHOP/DDIT3↑, 18,   CHOP/DDIT3↝, 1,   eIF2α↑, 5,   p‑eIF2α↑, 6,   ER Stress↑, 39,   ERStress↑, 1,   GRP78/BiP↓, 1,   GRP78/BiP↑, 12,   GRP94↑, 1,   HSP27↓, 2,   HSP70/HSPA5↓, 1,   HSP70/HSPA5↑, 2,   HSP72↑, 1,   HSP90↓, 7,   HTRA↓, 2,   IRE1↑, 4,   NPL4↓, 1,   PDI↑, 1,   PERK↓, 1,   PERK↑, 8,   p‑PERK↑, 1,   Proteasome↓, 3,   UPR↓, 1,   UPR↑, 11,   XBP-1↑, 1,   XBP-1↝, 1,  

Autophagy & Lysosomes(tgid=9) ⓘ

ATG13↑, 1,   ATG3↓, 1,   ATG3↑, 1,   ATG5↑, 6,   ATG7↑, 1,   autoF↓, 1,   autolysosome↑, 1,   Beclin-1/ATG6↓, 2,   Beclin-1/ATG6↑, 13,   CTSB↓, 1,   CTSD↓, 1,   CTSL↑, 1,   LC3‑Ⅱ/LC3‑Ⅰ↑, 5,   LC3B↑, 3,   LC3B-II↑, 3,   LC3II↓, 1,   LC3II↑, 11,   LC3s↓, 1,   LC3s↑, 2,   lysosome↓, 1,   MitoP↑, 1,   p62↓, 7,   p62↑, 6,   PARK2↑, 1,   SESN2↑, 1,   TumAuto↓, 3,   TumAuto↑, 57,   TumAuto↝, 1,  

DNA Damage & Repair(tgid=10) ⓘ

ATM↑, 1,   p‑ATM↑, 1,   ATR↑, 1,   DFF45↓, 1,   DNAdam↑, 64,   DNAdam⇅, 1,   mt-DNAdam↑, 1,   DNArepair↓, 1,   DNArepair↑, 1,   hTERT/TERT↓, 3,   MGMT↓, 1,   NHEJ↓, 1,   p16↑, 1,   P53?, 1,   P53↓, 3,   P53↑, 65,   P53↝, 3,   P53∅, 1,   p‑P53↑, 6,   PARP↓, 2,   PARP↑, 14,   p‑PARP↑, 2,   cl‑PARP↑, 63,   PARP1↓, 2,   PARP1↑, 2,   cl‑PARP1↑, 2,   PCNA↓, 23,   SAPK↑, 1,   Telomerase↓, 5,   TOP1↓, 2,   TOP2↓, 4,   TOP2↑, 1,   TP53↑, 1,   TRF2↓, 1,   γH2AX↑, 9,   γH2AX↝, 1,   p‑γH2AX↑, 2,  

Cell Cycle & Senescence(tgid=11) ⓘ

ANAPC2↑, 1,   AURKB↓, 1,   AURKB↑, 1,   BRD4↓, 1,   CC(CDKs/cyclins)↑, 1,   CDK1↓, 15,   CDK1↑, 1,   CDK1↝, 1,   CDK1/2/5/9↓, 1,   CDK2↓, 17,   CDK2↑, 2,   p‑CDK2↓, 1,   CDK4↓, 27,   CDK4↑, 3,   CDK4/6↓, 1,   CDK6↓, 7,   CDK6↑, 3,   CDK8↓, 1,   cellSen↑, 1,   CHK1↓, 2,   CHK1↑, 1,   CHK1↝, 1,   Chk2↑, 2,   p‑Chk2↑, 1,   Cyc↓, 3,   cycA1/CCNA1↓, 6,   cycA1/CCNA1↑, 1,   CycB/CCNB1↓, 21,   CycB/CCNB1↝, 1,   cycD1/CCND1↓, 74,   cycD1/CCND1↑, 1,   cycE/CCNE↓, 9,   cycE/CCNE↑, 1,   cycE1↓, 2,   cycF↑, 1,   E2Fs↓, 4,   GADD45A↑, 2,   Ki-67↓, 57,   Ki-67↑, 1,   mitA↑, 2,   p19↑, 1,   P21↓, 3,   P21↑, 58,   p27/CDKN1B↓, 2,   p27/CDKN1B↑, 19,   PLK1↓, 1,   pRB↓, 1,   pRB↑, 1,   RB1↓, 1,   RB1↑, 1,   p‑RB1↓, 2,   cl‑RB1↓, 1,   Securin↓, 2,   TubPol↓, 2,   TumCCA↓, 7,   TumCCA↑, 256,   β-Tubulin↓, 1,  

Proliferation, Differentiation & Cell State(tgid=12) ⓘ

4E-BP1↓, 1,   4E-BP1↑, 1,   p‑4E-BP1↓, 1,   ALDH↓, 7,   ALDH1A1↓, 2,   ALDH1A3↓, 1,   Axin2↑, 1,   BMI1↓, 4,   BMP7/OP1↓, 1,   CD133↓, 12,   CD133↑, 1,   CD24↓, 4,   CD34↓, 2,   CEBPB?, 1,   cFos↓, 4,   CSCs↓, 49,   CSCs↑, 2,   CSCsMark↓, 1,   Diff↑, 13,   EP4/PTGER4↑, 1,   FGF↓, 1,   FOSL1↑, 1,   Gli↓, 1,   Gli1↓, 20,   Gli1∅, 1,   GTPBP4↓, 1,   HH?, 1,   HH↓, 20,   HMGCR↓, 2,   HMGCR↑, 1,   Id1↓, 1,   IGF-1↓, 10,   IGF-1↑, 1,   IGFBP3↓, 1,   IGFBP3↑, 2,   Ki-67↓, 57,   Ki-67↑, 1,   Let-7↑, 1,   LRP6↓, 2,   mTORC1↓, 6,   Nanog↓, 12,   Nestin↓, 1,   NOTCH↓, 8,   NOTCH↑, 1,   NOTCH1↓, 8,   NOTCH1↝, 1,   NOTCH2↑, 2,   NOTCH3↓, 3,   p300↓, 1,   Piezo1↑, 2,   PTCH1↓, 8,   PTCH2↓, 1,   Shh↓, 7,   Smo↓, 8,   Smo∅, 1,   STAT1↓, 1,   Sufu↓, 1,   Sufu↑, 1,   TAZ↓, 2,   TumCG?, 11,   TumCG↓, 962,   TumCG↑, 18,   TumCG⇅, 2,   TumCG↝, 3,   TumCG∅, 6,   TumCP↓, 214,   TumCP↑, 6,   Wnt↓, 27,   Wnt/(β-catenin)↓, 4,  

Migration(tgid=13) ⓘ

AGRN↓, 1,   AKR1C2↓, 1,   AntiAg↑, 2,   AP-1↓, 4,   AP-1↝, 1,   ARG1/2↑, 1,   CA↓, 2,   Ca+2↓, 2,   Ca+2↑, 25,   Ca+2↝, 2,   i-Ca+2↑, 4,   Cal1↑, 1,   Cav1↓, 1,   Cav1↑, 1,   CCAT1↓, 1,   CD11b↓, 1,   i-Chl↑, 1,   COL11A1↓, 1,   CTNNB1↓, 1,   E-cadherin↓, 2,   E-cadherin↑, 43,   E-cadherin↝, 1,   EMT?, 1,   EMT↓, 64,   EMT↝, 1,   EpCAM↓, 1,   FAK↓, 11,   FAK↑, 1,   Fibronectin↓, 2,   Galectin-9↓, 1,   GIT1↓, 1,   GLI2↓, 5,   ITGA5↓, 2,   ITGB1↓, 3,   LEF1↓, 2,   MALAT1↓, 2,   MET↑, 1,   MMP1↓, 3,   MMP13↓, 2,   MMP15↓, 1,   MMP2↓, 54,   proMMP2↓, 1,   MMP3↓, 2,   MMP7↓, 6,   MMP9↓, 71,   MMPs↓, 8,   MTA1↓, 1,   MUC1↓, 1,   MUC1-C↓, 1,   N-cadherin↓, 27,   N-cadherin↝, 1,   Na+↑, 2,   NCAM↓, 1,   NFAT↑, 1,   p‑p44↓, 1,   PAK1↓, 1,   PCBP1↓, 1,   PDGF↓, 1,   Rac1↓, 1,   RECK↑, 1,   Rho↓, 2,   ROCK1↓, 1,   Slug↓, 11,   p‑SMAD2↓, 1,   SMAD3↓, 1,   Snail↓, 18,   SPARC↑, 2,   talin↓, 1,   TET1↓, 1,   TGF-β↓, 7,   TGF-β1↓, 2,   TIMP1↑, 4,   TIMP2↑, 4,   TRIB3↑, 2,   TSP-1↑, 2,   TumCA↓, 3,   TumCI?, 2,   TumCI↓, 112,   TumCI↑, 2,   TumCMig?, 2,   TumCMig↓, 123,   TumCMig↑, 2,   TumMeta?, 1,   TumMeta↓, 91,   TumMeta↑, 5,   TumPF↓, 4,   Twist↓, 8,   TXNIP↓, 1,   TXNIP↑, 2,   uPA↓, 7,   uPAR↓, 2,   Vim↓, 28,   Zeb1↓, 8,   Zeb1↑, 1,   ZEB2↓, 1,   α-SMA↓, 2,   α-tubulin↓, 4,   ac‑α-tubulin↑, 1,   β-catenin/ZEB1↓, 38,  

Angiogenesis & Vasculature(tgid=14) ⓘ

angioG↓, 89,   angioG↑, 2,   CD31/PECAM-1↓, 8,   CD31/PECAM-1↑, 1,   ECM/TCF↓, 3,   EGR1↑, 1,   EGR4↓, 1,   Endoglin↑, 1,   eNOS↓, 1,   HIF-1↓, 3,   Hif1a↓, 50,   Hif1a↑, 1,   Hif1a↝, 1,   NO↓, 5,   NO↑, 2,   VCAM-1↓, 3,   VEGF↓, 84,   VEGF↑, 2,   VEGFR1↓, 2,   VEGFR2/KDR/Flk1↓, 13,   VM↓, 1,  

Barriers & Transport(tgid=15) ⓘ

AQPs↓, 1,   BBB↑, 7,   CellMemb↓, 1,   CellMemb↑, 4,   CLDN1↓, 1,   CLDN7↑, 1,   EPR↑, 9,   GLUT1↓, 11,   GLUT1↑, 1,   GLUT2↓, 1,   GLUT3↓, 1,   GLUT3↑, 1,   GLUT4↓, 2,   IBI↑, 1,   K+↑, 1,   memfluid↓, 1,   MMP?, 1,   MMP↓, 134,   MMP↑, 5,   MPT↑, 4,   Na+↑, 2,   NHE1↓, 1,   OCLN↑, 1,   TRPM7↑, 2,   TRPV1↓, 1,   TRPV1↑, 1,   TRPV1↝, 1,  

Immune & Inflammatory Signaling(tgid=16) ⓘ

ALC∅, 1,   CCL20↑, 1,   CD155↓, 1,   CD25+↓, 2,   CD4+↓, 3,   CD4+↑, 10,   CD44↓, 18,   CD44↝, 1,   CD47↓, 1,   CD8+↑, 12,   cDC2↓, 2,   p‑cDC2↓, 2,   cGAS–STING↑, 1,   CLP↑, 1,   COX1?, 1,   COX2/PTGS2?, 1,   COX2/PTGS2↓, 31,   COX2/PTGS2↑, 2,   CXCc↓, 1,   CXCL1↓, 1,   CXCL12↓, 1,   CXCL9↓, 1,   CXCR4↓, 9,   DCells↑, 3,   DR4↑, 2,   DR6↑, 1,   FOXP3↓, 1,   FoxP3+↓, 2,   Gal-3↓, 2,   GM-CSF↓, 3,   HLA-I/II↑, 1,   HMGB1↓, 4,   HMGB1↑, 1,   ICAM-1↓, 8,   IFN-γ↓, 2,   IFN-γ↑, 3,   IL1↓, 5,   IL1↑, 2,   IL10↓, 2,   IL10↑, 2,   IL12↓, 1,   IL12↑, 4,   IL18↑, 2,   IL1β↓, 9,   IL1β↑, 1,   IL2↓, 3,   IL2↑, 3,   IL4↑, 1,   IL6?, 1,   IL6↓, 22,   IL6↑, 2,   IL8↓, 7,   Imm↑, 22,   Imm↝, 1,   Inflam↓, 27,   Inflam↝, 1,   LPS↓, 1,   pol-M1↑, 1,   M2 MC↓, 1,   M2 MC↑, 1,   pol-M2 MC↓, 2,   Macrophages↑, 1,   MCP1/CCL2↓, 2,   MDSCs↓, 1,   mPGES-1↓, 1,   MyD88↓, 1,   NAF1↓, 1,   NF-kB↓, 111,   NF-kB↑, 5,   NF-kB⇅, 1,   NF-kB↝, 1,   p‑NF-kB↓, 3,   NK cell↑, 8,   NLRP3↓, 2,   NLRP3↑, 3,   p50↓, 1,   p65↓, 7,   p‑p65↓, 4,   PD-1↓, 2,   PD-L1↓, 19,   PD-L2↓, 1,   PGE2↓, 9,   PSA↓, 12,   T-Cell↑, 8,   TCF↓, 3,   Th1 response↑, 1,   TILs↑, 2,   TIM-3↓, 2,   TIRAP↓, 1,   TLR4↓, 3,   TLR4↝, 1,   TNF-α?, 1,   TNF-α↓, 13,   TNF-α↑, 4,   TNFRSF25/DR3/APO3/LARD/TRAMP/WSL1↑, 1,   Treg lymp↓, 2,  

Cellular Microenvironment(tgid=17) ⓘ

ADAM17↓, 1,   GFAP↓, 1,   pH↓, 2,   pH↑, 3,   pH↝, 1,   e-pH↑, 10,   i-pH↓, 1,   i-pH↑, 1,   TAMS↓, 1,  

Synaptic & Neurotransmission(tgid=18) ⓘ

SYN1↑, 1,  

Protein Aggregation(tgid=19) ⓘ

BACE/β-secretase↓, 1,   XO↓, 1,  

Hormonal & Nuclear Receptors(tgid=20) ⓘ

ACTH↓, 1,   AR↓, 18,   COMT↑, 1,   CYP11A1↓, 1,   CYP19↓, 1,   DHT↓, 1,   ER-α36↓, 1,   ER(estro)↓, 2,   ERα/ESR1↓, 2,   ERβ/ESR2↑, 2,   FGF21↓, 1,   GR↓, 1,   HSD3B↓, 1,   PPARα↑, 1,   PPARα↝, 1,   PPARγ↑, 2,   RANKL↓, 2,   SRD5A1↑, 1,   StAR↓, 1,   SXR↓, 1,   testos↓, 1,  

Drug Metabolism & Resistance(tgid=21) ⓘ

ABC↓, 1,   ABCG2↓, 1,   BioAv↓, 27,   BioAv↑, 24,   BioAv↝, 11,   ChemoSen?, 1,   ChemoSen↓, 4,   ChemoSen↑, 155,   ChemoSen∅, 2,   CompStab↓, 2,   CompStab↑, 1,   CompStab↝, 2,   CYP1A1↓, 1,   CYP1A1↑, 1,   CYP3A4↓, 1,   DDS↑, 1,   Dose?, 4,   Dose↓, 6,   Dose↑, 7,   Dose⇅, 2,   Dose↝, 104,   Dose∅, 13,   DrugR↓, 1,   eff?, 1,   eff↓, 84,   eff↑, 107,   eff↝, 16,   eff∅, 2,   Half-Life↓, 6,   Half-Life↑, 2,   Half-Life↝, 8,   Half-Life∅, 2,   MDR1↓, 6,   MRP1/ABCC1↓, 3,   P-gp/ABCB1↓, 11,   P-gp/ABCB1↝, 1,   P-gp/ABCB1∅, 1,   P450↓, 2,   P450↑, 1,   RadioS?, 1,   RadioS↑, 44,   RadioS↝, 1,   selectivity?, 1,   selectivity↓, 3,   selectivity↑, 128,   selectivity↝, 1,   selectivity∅, 1,   Synergy↑, 100,   TET2↑, 1,  

Clinical Biomarkers(tgid=22) ⓘ

AFP↓, 1,   ALAT↓, 5,   ALAT∅, 1,   AR↓, 18,   ascitic↓, 2,   AST↓, 4,   AST∅, 1,   BG↓, 4,   BMD↑, 3,   BP↓, 1,   BRAF↓, 2,   BRAF↑, 1,   EGFR↓, 29,   EGFR↝, 1,   p‑EGFR↓, 1,   ERα/ESR1↓, 2,   EZH2↓, 3,   Ferritin↓, 3,   Ferritin↑, 1,   FOXM1↓, 2,   HER2/EBBR2↓, 10,   p‑HER2/EBBR2↓, 1,   hTERT/TERT↓, 3,   IL6?, 1,   IL6↓, 22,   IL6↑, 2,   KeyT↑, 1,   LDH↓, 8,   LDH↑, 2,   p‑LDH↓, 1,   Myc↓, 5,   PD-L1↓, 19,   PSA↓, 12,   PSADT↑, 1,   SUZ12↓, 1,   TG/TAG↓, 1,   TP53↑, 1,   TRIB3↑, 2,   Tumccf↓, 3,  

Functional Outcomes(tgid=23) ⓘ

AntiAge↑, 2,   AntiArt↑, 1,   AntiCan↓, 1,   AntiCan↑, 62,   AntiCan?, 1,   antiCG↓, 1,   antiNeop↑, 4,   antiNeop∅, 1,   AntiTum↑, 40,   Appetite↑, 1,   BowelM↑, 1,   breath↑, 1,   cachexia↓, 3,   cardioP↑, 7,   CardioT↓, 1,   chemoP↓, 1,   chemoP↑, 24,   chemoPv↑, 19,   ChemoSideEff↓, 7,   cognitive↑, 1,   fatigue∅, 1,   FTO↑, 1,   hepatoP↑, 5,   hepatoP∅, 1,   kidSt↓, 1,   motorD↑, 1,   neuroP↑, 5,   Obesity↓, 1,   OS↑, 62,   OS⇅, 1,   Pain↓, 5,   PDE4↓, 1,   QoL↑, 7,   QoL∅, 2,   radioP↑, 7,   Remission↑, 5,   Risk↓, 28,   Risk↑, 1,   Sleep↑, 1,   Strength↑, 4,   toxicity↓, 49,   toxicity↑, 4,   toxicity⇅, 1,   toxicity↝, 14,   toxicity∅, 9,   TumNum↓, 3,   TumVol↓, 38,   TumW↓, 22,   Weight↑, 4,   Weight∅, 10,  

Infection & Microbiome(tgid=24) ⓘ

AntiBio↑, 1,   AntiP↑, 2,   Bacteria↓, 3,   GutMicro↑, 13,   Sepsis↓, 1,  

Ingredients & Constituents(tgid=25) ⓘ

Ingr?, 2,   Ingr↝, 8,  
Total Targets: 1168

Pathway results for Effect on Normal Cells:


Redox & Oxidative Stress(tgid=1) ⓘ

antiOx↓, 7,   antiOx↑, 50,   ARE↑, 1,   Catalase↑, 12,   DPPH↓, 1,   GPx↑, 12,   GPx1↑, 1,   GSH↓, 2,   GSH↑, 19,   GSR↑, 3,   GSTs↑, 6,   H2O2↓, 2,   HO-1↑, 11,   lipid-P↓, 14,   MDA↓, 11,   NQO1↑, 1,   NRF2↑, 16,   ROS↓, 52,   ROS↑, 4,   ROS∅, 2,   mt-ROS↓, 1,   SOD↑, 18,   SOD1↑, 1,   SOD2↓, 1,   TBARS↓, 1,   Trx↓, 1,   Trx↑, 1,  

Metal & Cofactor Biology(tgid=2) ⓘ

IronCh↑, 1,  

Mitochondria & Bioenergetics(tgid=3) ⓘ

EGF↓, 1,   ETC↝, 1,   mitResp↑, 1,   OCR↓, 1,   OXPHOS↑, 1,   SIRT3↑, 1,  

Core Metabolism/Glycolysis(tgid=4) ⓘ

5LO↓, 5,   adiP↑, 1,   ALAT?, 1,   ALAT↓, 6,   AMPK↓, 1,   AMPK↑, 4,   ATP↓, 1,   ATP↑, 1,   ECAR∅, 1,   glucose↓, 3,   GlucoseCon↑, 3,   GSK‐3β↓, 1,   GSK‐3β↑, 1,   LDL↓, 6,   lipidLev↓, 1,   NAD↓, 1,   NADPH↓, 1,   PONs↓, 1,   SIRT1↑, 6,  

Cell Death(tgid=5) ⓘ

Apoptosis↓, 5,   Apoptosis↑, 1,   ASC↓, 1,   BAX↓, 3,   BAX↑, 1,   Bax:Bcl2↓, 1,   Bcl-2↓, 1,   Bcl-2↑, 1,   Casp↓, 1,   Casp1↓, 2,   Casp3↓, 4,   Casp3↑, 1,   cl‑Casp8↑, 1,   Casp9↓, 2,   Cyt‑c↓, 2,   Cyt‑c↑, 1,   Ferroptosis↑, 1,   iNOS↓, 7,   iNOS↑, 1,   necrosis↓, 1,   survivin↓, 1,  

Kinase & Signal Transduction(tgid=6) ⓘ

Akt↓, 2,   p‑Akt↑, 1,   Akt2↓, 1,   CREB↑, 1,   p‑CREB↑, 1,   ERK↑, 2,   IKKα↓, 1,   JNK↓, 1,   JNK↑, 1,   MAPK↓, 2,   MAPK↑, 1,   mTOR↓, 2,   mTOR↑, 1,   PTEN↓, 1,   STAT↓, 1,  

Transcription & Epigenetics(tgid=7) ⓘ

AntiThr↑, 3,   ATF4↓, 1,   cJun↓, 1,   cMyc↓, 1,   FOXO3↑, 1,   other?, 1,   other↓, 2,   other↑, 6,   other↝, 2,   tumCV↓, 1,  

Protein Folding & ER Stress(tgid=8) ⓘ

CHOP/DDIT3↓, 1,   HSP27↑, 1,   HSP70/HSPA5↑, 1,   HSPs↓, 1,  

Autophagy & Lysosomes(tgid=9) ⓘ

Beclin-1/ATG6↓, 1,   LC3II↓, 1,  

DNA Damage & Repair(tgid=10) ⓘ

DNAdam↓, 4,   P53↓, 2,   PCNA↓, 1,  

Cell Cycle & Senescence(tgid=11) ⓘ

CDK2↓, 1,   CDK4↓, 1,   cycD1/CCND1↓, 2,   cycE/CCNE↓, 1,   GADD34↓, 1,   P21↓, 2,   RB1↓, 1,  

Proliferation, Differentiation & Cell State(tgid=12) ⓘ

Diff↑, 1,   IGF-1↑, 1,   neuroG↑, 1,   TumCG↓, 5,   TumCG↑, 1,   TumCG∅, 1,   TumCP↓, 1,   tyrosinase↓, 1,  

Migration(tgid=13) ⓘ

AntiAg↑, 4,   AP-1↓, 2,   BACH1↓, 1,   Ca+2↓, 3,   Ca+2↑, 2,   Ca+2∅, 1,   i-Ca+2↓, 1,   EMT↓, 1,   MLC2/MYL9↝, 1,   MMP9↓, 1,   MMPs↓, 1,   Snail↑, 1,   TGF-β↓, 2,   TIMP1↓, 1,   TumCI↓, 1,   TumMeta↓, 1,   Twist↑, 1,   Vim↑, 1,  

Angiogenesis & Vasculature(tgid=14) ⓘ

angioG↓, 1,   angioG↑, 1,   HIF-1↓, 1,   Hif1a↓, 1,   Hif1a↑, 1,   HIF2a↑, 1,   NO↓, 5,   VCAM-1↓, 2,   VEGF↓, 1,  

Barriers & Transport(tgid=15) ⓘ

BBB↓, 1,   BBB↑, 3,   BBB↝, 2,   CellMemb↑, 1,   GLUT2↑, 1,   GLUT3↑, 1,   GLUT4↑, 2,   MMP↓, 1,   MMP↑, 2,   OCLN↝, 1,   TJ↑, 1,   TRPC1↓, 1,   TRPV1↑, 1,   ZO-1↑, 1,  

Immune & Inflammatory Signaling(tgid=16) ⓘ

CD19↑, 1,   CD4+↑, 2,   CD8+↑, 1,   COX1↓, 3,   COX2/PTGS2↓, 13,   HMGB1↓, 1,   ICAM-1↓, 1,   IFN-γ↓, 2,   IFN-γ↑, 1,   IL1↓, 1,   IL10↓, 1,   IL10↑, 2,   IL12↓, 1,   IL17↓, 2,   IL1β↓, 7,   IL2↑, 1,   IL6↓, 14,   IL8↓, 2,   Imm↓, 1,   Imm↑, 5,   Inflam↓, 57,   Inflam↑, 1,   IRF3↓, 1,   MyD88↓, 1,   Neut↑, 1,   NF-kB↓, 15,   NK cell↑, 2,   NLRP3↓, 2,   NLRP3↑, 1,   PGE2↓, 5,   TLR2↓, 2,   TLR4↓, 5,   TNF-α↓, 13,   TNF-α↑, 1,   TRIF↓, 1,   VitD↑, 1,  

Cellular Microenvironment(tgid=17) ⓘ

pH↝, 1,  

Synaptic & Neurotransmission(tgid=18) ⓘ

5HT↓, 1,   5HT↑, 1,   Ach↑, 1,   AChE↓, 8,   AChE↑, 1,   AChE↝, 1,   BDNF↓, 1,   BDNF↑, 6,   ChAT↑, 1,   GABA↑, 1,   MAOA↓, 1,   NGF↑, 1,   TrkB↑, 1,   β-Endo↑, 1,  

Protein Aggregation(tgid=19) ⓘ

Aβ↓, 6,   XO↓, 1,  

Hormonal & Nuclear Receptors(tgid=20) ⓘ

PPARα↝, 1,   PPARγ↓, 1,   PPARγ↑, 3,  

Drug Metabolism & Resistance(tgid=21) ⓘ

BioAv?, 1,   BioAv↓, 11,   BioAv↑, 24,   BioAv↝, 7,   BioEnh↑, 3,   CompStab↑, 1,   CYP3A2↓, 1,   Dose?, 2,   Dose⇅, 1,   Dose↝, 4,   eff↑, 4,   Half-Life↓, 3,   Half-Life↝, 3,   Half-Life∅, 1,   P450↓, 3,   selectivity↑, 3,   Synergy↑, 3,  

Clinical Biomarkers(tgid=22) ⓘ

ALAT?, 1,   ALAT↓, 6,   ALP↓, 1,   AST↓, 7,   BMD↑, 2,   BP↓, 3,   colonLen↑, 1,   CRP↓, 4,   hs-CRP↓, 1,   IL6↓, 14,   LDH↓, 2,   LDH↑, 1,   TC↓, 1,   VitD↑, 1,  

Functional Outcomes(tgid=23) ⓘ

Analgesic↑, 1,   AntiAge↑, 3,   antiAll↑, 3,   AntiArt↑, 4,   AntiCan↑, 6,   AntiDiabetic↑, 8,   AntiTum↑, 2,   cardioP↑, 27,   chemoP↑, 5,   chemoPv↑, 6,   cognitive↑, 12,   DCR∅, 1,   hepatoP↑, 20,   memory↑, 13,   motorD↑, 1,   neuroP↑, 36,   ORR∅, 1,   OS↑, 3,   Pain↓, 2,   PDE4↓, 1,   PFS∅, 1,   QoL↑, 1,   radioP↑, 2,   RenoP↓, 1,   RenoP↑, 4,   Stroke↓, 2,   toxicity↓, 40,   toxicity↑, 3,   toxicity↝, 7,   toxicity∅, 12,   Weight↓, 1,   Wound Healing↑, 1,  

Infection & Microbiome(tgid=24) ⓘ

AntiBio↑, 1,   AntiFungal↑, 2,   AntiP↑, 2,   AntiViral↑, 5,   Bacteria↓, 11,   GutMicro↑, 6,   Sepsis↓, 1,  

Ingredients & Constituents(tgid=25) ⓘ

Ingr↑, 2,   Ingr↝, 5,  
Total Targets: 292

Scientific Paper Hit Count for: TumCG, Tumor cell growth
29 Curcumin
29 Magnetic Fields
19 Phenethyl isothiocyanate
17 Quercetin
17 Sulforaphane (mainly Broccoli)
17 Magnetic Field Rotating
14 Berberine
14 EGCG (Epigallocatechin Gallate)
13 Silver-NanoParticles
13 Chemotherapy
13 Shikonin
12 Vitamin C (Ascorbic Acid)
12 Magnolol
12 Bicarbonate(Sodium)
11 Alpha-Lipoic-Acid
11 Melatonin
11 Baicalein
11 Garcinol
11 phytic acid, Inositol hexakisphosphate
10 Benzyl isothiocyanate
10 Capsaicin
10 Apigenin (mainly Parsley)
10 chaetocin
10 Fisetin
9 Cucurbitacin
9 Silymarin (Milk Thistle) silibinin
9 Resveratrol
9 Dichloroacetate
9 Deguelin
9 Formononetin
9 Phenylbutyrate
8 Astragalus
8 Radiotherapy/Radiation
8 Artemisinin
8 salinomycin
8 diet FMD Fasting Mimicking Diet
8 Emodin
8 Gambogic Acid
8 Ginkgetin
8 Honokiol
8 Ivermectin
8 Matrine
8 Magnesium
8 Pterostilbene
8 Urolithin
7 Allyl isothiocyanate
7 Cisplatin
7 Allicin (mainly Garlic)
7 HydroxyCitric Acid
7 Ashwagandha(Withaferin A)
7 immunotherapy
7 Boron
7 Boswellia (frankincense)
7 Crocetin
7 Isoliquiritigenin
7 Lycopene
7 mebendazole
7 methylseleninic acid
6 Metformin
6 Betulinic acid
6 Chrysin
6 Coenzyme Q10
6 Gemcitabine (Gemzar)
6 diet Methionine-Restricted Diet
6 Sulfasalazine
6 Indole-3-carbinol
6 Inulin Prebiotic
6 itraconazole
6 Juglone
6 Rosmarinic acid
6 α-Santalol/Sandalwood oil
5 chitosan
5 doxorubicin
5 Paclitaxel/Taxol
5 Berbamine
5 Beta-Caryophyllene
5 Centella asiatica / Gotu kola → asiaticoside
5 Citric Acid
5 Diindolylmethane
5 Dandelion Root
5 Eugenol
5 Gallic acid
5 Graviola
5 isoquercitrin
5 Linalool
5 Luteolin
4 3-bromopyruvate
4 Fenbendazole
4 Astaxanthin
4 Atorvastatin
4 Dipyridamole
4 Brucea javanica
4 Butyrate
4 Caffeic Acid Phenethyl Ester (CAPE)
4 Cynaropicrin
4 Docosahexaenoic Acid
4 Disulfiram
4 Evodiamine
4 Flaxseed/Linseed
4 Genistein (soy isoflavone)
4 Hydrogen Gas
4 Hyperoside
4 Isobavachalcone
4 Inositol
4 Nimbolide
4 Marjoram (Origanum majorana)
4 Terpinen-4-ol / Tea Tree Oil
4 Piperine
4 Piperlongumine
4 Selenite (Sodium)
4 Thymoquinone
4 Vitamin K2
4 VitK3,menadione
4 Zyflamend
3 Caffeic acid
3 Diclofenac
3 Baicalin
3 Bufalin/Huachansu
3 brusatol
3 Bruteridin(bergamot juice)
3 NTP, Non-Thermal Plasma,Cold Atmospheric Plasma
3 Carvacrol
3 Celastrol
3 Chlorogenic acid
3 Selenium NanoParticles
3 Copper and Cu NanoParticles
3 Photodynamic Therapy
3 tamoxifen
3 Ellagic acid
3 eicosapentaenoic acid
3 Fucoidan
3 Geraniol
3 Ginger/6-Shogaol/Gingerol
3 Glabrescione B
3 Gossypol/AT-101
3 HydroxyTyrosol
3 MCT, metronomic chemo
3 Isorhamnetin
3 Licochalcone A
3 Licorice
3 Lemongrass Extract/Citral
3 SDG/lignans
3 Modified Citrus Pectin
3 Mangiferin
3 Niclosamide (Niclocide)
3 Patchouli Oil (Pogostemon cablin)
3 Propyl gallate
3 Plumbagin
3 Aflavin-3,3′-digallate
2 2-DeoxyGlucose
2 Auranofin
2 5-fluorouracil
2 Phyllanthus emblica/Emblica officinalis/Amla / Indian Gooseberry
2 Andrographis
2 Anethole/trans-Anethole
2 Fennel Oil/Foeniculum vulgare
2 Ascorbyl Palmitate
2 Biochanin A
2 Bifidobacterium
2 Bromelain
2 α-Bisabolol / Chamomile oil
2 Carnosic acid
2 Cinnamon
2 Cynara scolymus/Globe Artichoke/Artichoke Extract
2 Polyphenols
2 Chlorella (Chlorella vulgaris)
2 Cyclopamine
2 Oxygen, Hyperbaric
2 diet Short Term Fasting
2 D-limonene
2 Ginkgo biloba-EGb 761
2 ferumoxytol
2 Galloflavin
2 Ginkgo biloba
2 Ginkgolide B
2 Grapeseed extract
2 Hydroxycinnamic-acid
2 iodine
2 Isothiocyanates
2 Isovitexin
2 Kaempferol
2 Lutein
2 Methylene blue
2 Moringin
2 Methylsulfonylmethane
2 Mushroom Chaga, Inonotus obliquus
2 Mushroom Lion’s Mane, Hericium erinaceus
2 Mushroom Maitake
2 Oroxylin-A
2 Oleuropein
2 Orlistat
2 Phycocyanin
2 Psoralidin
2 Hyperthermia
2 EMF
2 Oxaliplatin
2 Spermidine
2 Ursolic acid
2 Vitexin
2 Whole Body Vibration
1 1,8-Cineole
1 Açaí, Euterpe oleracea
1 Anzaroot, Astragalus fasciculifolius Bioss
1 octreotide
1 Acetyl-l-carnitine
1 DTS(dibenzyl trisulphide) from Anamu
1 Angelica archangelica / Garden Angelica
1 Anti-oxidants
1 5-Aminolevulinic acid
1 Aloe anthraquinones
1 beta-glucans
1 temozolomide
1 Bacopa monnieri
1 Black Rice, Oryza sativa
1 Bullatacin
1 Caffeine
1 urea
1 Cat’s Claw
1 Cannabidiol
1 Celecoxib
1 Chocolate
1 Cranberry
1 Calorie Restriction Mimetics
1 Carvone
1 Bicalutamide
1 CUSP9
1 Dichloroacetophenone(2,2-)
1 Dasatinib/Phyrago
1 Bortezomib
1 Date Fruit Extract
1 diet Ketogenic
1 diet Plant based
1 Ormeloxifene (Centchroman)
1 Aspirin
1 Zinc
1 Echinacea
1 PXD, phenoxodiol
1 Sorafenib (brand name Nexavar)
1 Electrical Pulses
1 erastin
1 Eurycomanone
1 Flaxseed Oil
1 Shilajit/Fulvic Acid
1 Ginkgolic acids
1 Hibiscus sabdariffa
1 capecitabine
1 L-Theanine
1 Lactobacillus
1 probiotics
1 Laetrile B17 Amygdalin
1 Lapachol
1 Lasiodin
1 Lactoferrin/Talactoferrin
1 MBE, Maqui berry
1 MCT oil
1 Methyl Jasmonate
1 vp16, etoposide
1 Methylglyoxal
1 magnetic nanoparticles
1 Morin
1 Mistletoe/Viscum album Extracts
1 Naringin
1 Noscapine
1 Aromatherapy
1 Purple Corn / Purple Maize
1 Parthenolide
1 Broccoli
1 raloxifen
1 Salvia officinalis
1 Vorinostat
1 Selenium
1 irinotecan
1 Salvia miltiorrhiza
1 Saikosaponin B1 and D
1 Sutherlandioside D
1 cetuximab
1 Taurine
1 Tomatine
1 triptolide
1 Tumor Treating Fields
1 Turmerones
1 Usnic acid
1 Vitamin B1/Thiamine
1 Vitamin B5,Pantothenic Acid
1 Transarterial Chemoembolization
1 Walnut
1 γ-Tocotrienol
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:%  Cells:%  prod#:%  Target#:323  State#:%  Dir#:%
wNotes=0 sortOrder:rid,rpid

 

Home Page